Efficacy Capital, Ltd.

Filings by Efficacy Capital, Ltd. span 2 companies, the busiest being Repros Therapeutics Inc. and Aeolus Pharmaceuticals, Inc. Between 17 October 2007 and 16 March 2011, the trades on record add up to 62 filings.

The open-market side counts 36 purchases for €16.9M alongside 24 sales for €4.4M. Taken together, the purchases exceed the sales by €12.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2011 alone, the filings show no purchases and 4 sales.

In size, the median ticket on the buying side is €219k.

Most recently, on 17 March 2011, the filings show an open-market sale worth €1.7M in Aeolus Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 6,563 days ago, on 4 November 2008. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.